Atypical antipsychotic administration during late pregnancy: Placental passage and obstetrical outcomes

American Journal of Psychiatry

Volumn 164, Issue 8, 2007, Pages 1214-1220

  Newport, D Jeffrey ^a   Calamaras, Martha R ^b   DeVane, C Lindsay ^b   Donovan, Jennifer ^b   Beach, Aquila J ^b   Winn, Stephanie ^b   Knight, Bettina T ^b   Gibson, Bryan B ^b   Viguera, Adele C ^b   Owens, Michael J ^b   Nemeroff, Charles B ^b   Stowe, Zachary N ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; HYPNOTIC AGENT; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; THIRD TRIMESTER PREGNANCY;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DIBENZOTHIAZEPINES; FEMALE; FETAL BLOOD; HALOPERIDOL; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; RISPERIDONE;

EID: 34548100318     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2007.06111886     Document Type: Article

References (16)

1. Boulton DW, Markowitz JS, DeVane CL: A high-performance liquid chromatography assay with ultraviolet detection for olanzapine in human plasma and urine. J Chromatogr B Biomed Sci Appl 2001; 759:319-323
2. Llorca PM, Coudore F, Corpelet C, Buyens A, Hoareau M, Eschalier A: Integration of olanzapine determinations in an HP-LC-diode array detection system for routine psychotropic drug monitoring. Clin Chem 2001; 47:1719-1721
3. Pan L, Rosseel MT, Belpaire FM: Comparison of two high-performance liquid chromatographic methods for monitoring plasma concentrations of haloperidol and reduced haloperidol. Ther Drug Monit 1998; 20:224-230
4. Titier K, Deridet E, Cardone E, Abouelfath A, Moore N: Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in plasma after overdose. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 772:373-378
5. Schenker S, Yang Y, Mattiuz E, Tatum D, Lee M: Olanzapine transfer by human placenta. Clin Exp Pharmacol Physiol 1999; 26:691-697
6. Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D: Placental passage of antidepressant medications. Am J Psychiatry 2003; 160:993-996
7. Loughhead AM, Stowe ZN, Newport DJ, Ritchie JC, DeVane CL, Owens MJ: Placental passage of tricyclic antidepressants. Biol Psychiatry 2006; 59:287-290
8. DeVane CL, Stowe ZN, Donovan JL, Newport DJ, Pennell PB, Ritchie JC, Owens MJ, Wang JS: Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities. J Psychopharmacol 2006; 20(suppl):54-59
9. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson ML: Division of vital statistics: births: final data for 2003. Natl Vital Stat Rep 2005; 54:1-116
10. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S: Division of vital statistics: births: final data for 2004. Natl Vital Stat Rep 2006; 55:1-104
11. Odlind V, Haglund B, Pakkanen M, Olausson PO: Deliveries, mothers and newborn infants in Sweden, 1973-2000: trends in obstetrics as reported to the Swedish Medical Birth Register. Acta Obstet Gynecol Scand 2003; 82:516-528
12. State of New Jersey Department of Health and Senior Services: New Jersey Health Statistics, Births, 1997-2003. http://www.state.nj.us/health/chs/stats03/ natality.shtml
13. McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O, Levinson A, Zipursky RB, Einarson A: Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry 2005; 66:444-449
14. Laegreid L, Olegard R, Walstrom J, Conradi N: Teratogenic effects of benzodiazepine use during pregnancy. J Pediatr 1989; 114:126-131
15. Drago F, Di Leo F, Giardina L: Prenatal stress induces body weight deficit and behavioural alterations in rats: the effect of diazepam. Eur Neuropsychopharmacol 1999; 9:239-245
16. Newport DJ, Stowe ZN: Psychopharmacology during pregnancy and lactation, in Essentials of Clinical Psychopharmacology, 2nd ed. Edited by Schatzberg A, Nemeroff CB. Washington, DC, American Psychiatric Publishing, 2006, pp 745-774